polygodial has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burth, P; Calixto, JB; Dasari, R; De Carvalho, A; De La Chapa, JJ; Dybdal-Hargreaves, NF; Evidente, A; Frolova, LV; Gautier, M; Glass, R; Gonzales, CB; Hague, F; Kälin, RE; Kiss, R; Kornienko, A; Mathieu, V; Medellin, DC; Middleton, KN; Munirathinam, G; Pelly, SC; Pillai, A; Rogelj, S; Rossato, MF; van Otterlo, WA; Volmar, MN | 1 |
1 other study(ies) available for polygodial and paclitaxel
Article | Year |
---|---|
Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.
Topics: Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Polygonum; Pyrroles; Sesquiterpenes; Structure-Activity Relationship | 2015 |